Home | Impressum | Sitemap | KIT

Andrew C. Cato - Selected Publications


  1. Tripartite Motif Proteins-A Protein Family Strongly Linked to Cancer.
    Elabd, S.; Cato, A. C. B.; Blattner, C.
    2017. Annals of Pharmacology and Pharmaceutics, 2 (10), 1-5
  2. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.
    Cato, L.; Neeb, A.; Sharp, A.; Buzón, V.; Ficarro, S. B.; Yang, L.; Muhle-Goll, C.; Kuznik, N. C.; Riisnaes, R.; Nava, D.; Olivier, R.; Victor, A.; Guillaume, G.; Ntim, A. E. A.; Westerling, T.; Dolling, D.; Rescigno, P.; Figueiredo, I.; Fauser, F.; Wu, J.; Rottenberg, J. T.; Shatkina, L.; Ester, C.; Luy, B.; Puchta, H.; Troppmair, J.; Jung, N.; Bräse, S.; Strähle, U.; Marto, J. A.; Nienhaus, G. U.; Al-Lazikani, B.; Salvatella, X.; de Bono, J.; Cato, A. C. B.; Brown, M.
    2017. eLife, 6, e27159. doi:10.7554/eLife.27159
  3. An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation.
    Oppong, E.; Stier, G.; Gaal, M.; Seeger, R.; Stoeck, M.; Delsuc, M.-A.; Cato, A. C. B.; Kieffer, B.
    2017. Biomolecules, 7 (2), 44. doi:10.3390/biom7020044
  4. Polymer pen lithography for biosensing and biomedical applications.
    Hirtz, M.; Kumar, R.; Bog, U.; Sekula-Neuner, S.; Liu, H. Y.; Pantel, K.; Cato, A. C. B.; Fuchs, H.
    2016. NANOCON 2016 - Conference Proceedings, 8th International Conference on Nanomaterials - Research and Application; Hotel Voronez IBrno; Czech Republic; 19 October 2016 through 21 October 2016, 408-413, TANGER Ltd.
  5. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.
    Polanco, M. J.; Parodi, S.; Piol, D.; Stack, C.; Chivet, M.; Contestabile, A.; Miranda, H. C.; Lievens, P. M.-J.; Espinoza, S.; Jochum, T.; Rocchi, A.; Grunseich, C.; Gainetdinov, R. R.; Cato, A. C. B.; Lieberman, A. P.; La Spada, A. R.; Sambataro, F.; Fischbeck, K. H.; Gozes, I.; Pennuto, M.
    2016. Science translational medicine, 8 (370), 370ra181. doi:10.1126/scitranslmed.aaf9526
  6. Click-Chemistry Based Allergen Arrays Generated by Polymer Pen Lithography for Mast Cell Activation Studies.
    Kumar, R.; Bonicelli, A.; Sekula-Neuner, S.; Cato, A. C. B.; Hirtz, M.; Fuchs, H.
    2016. Small, 12 (38), 5330–5338. doi:10.1002/smll.201601623
  7. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
    Groner, A.; Cato, L.; de Tribolet-Hardy, J.; Bernasocchi, T.; Janouskova, H.; Melchers, D.; Houtman, R.; Cato, A.; Tschopp, P.; Gu, L.; Corsinotti, A.; Zhong, Q.; Fankhauser, C.; Fritz, C.; Poyet, C.; Wagner, U.; Guo, T.; Aebersold, R.; Garraway, L.; Wild, P. J.; Theurillat, J.-P.; Brown, M.
    2016. Cancer cell, 29 (6), 846-858. doi:10.1016/j.ccell.2016.04.012
  8. Superporous Poly(ethylene glycol) Diacrylate Cryogel with a Defined Elastic Modulus for Prostate Cancer Cell Research.
    Göppert, B.; Sollich, T.; Abaffy, P.; Cecilia, A.; Heckmann, J.; Neeb, A.; Bäcker, A.; Baumbach, T.; Gruhl, F. J.; Cato, A. C. B.
    2016. Small, 12 (29), 3985-3994. doi:10.1002/smll.201600683
  9. Abstract 4677: Control of androgen receptor function by the genomic action of the cochaperone Bag-1L.
    Cato, L.; Neeb, A.; Adelmant, G.; Ficarro, S.; Westerling, T.; Marto, J. A.; Cato, A. C.; Brown, M.
    2015. Cancer research, 75 (15, Supplement), Art. Nr.: 4677. doi:10.1158/1538-7445.AM2015-4677
  10. Effects of glucocorticoids in the immune system.
    Oppong, E.; Cato, A. C. B.
    2015. Advances in experimental medicine and biology, 872, 217-233. doi:10.1007/978-1-4939-2895-8_9
  11. Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-Binding Motif.
    Jehle, K.; Cato, L.; Neeb, A.; Muhle-Goll, C.; Jung, N.; Smith, E. W.; Buzon, V.; Carbo, L. R.; Estebanez-Perpina, E.; Schmitz, K.; Fruk, L.; Luy, B.; Chen, Y.; Cox, M. B.; Bräse, S.; Brown, M.; Cato, A. C. B.
    2014. Journal of biological chemistry, 289 (13), 8839-8851. doi:10.1074/jbc.M113.534859
  12. Analysis of the conformation of the androgen receptor in spinal bulbar muscular atrophy by atomic force microscopy.
    Jochum, T.; Cato, A. C. B.
    2014. Castoria, G. [Hrsg.] Steoid Receptors : Methods and Protocols New York, N.Y. : Springer Science and Business Media, 2014 (Methods in Molecular Biology ; 1204), 197-204
  13. Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
    Neeb, A.; Hefele, S.; Bormann, S.; Parson, W.; Adams, F.; Wolf, P.; Miernik, A.; Schoenthaler, M.; Kroenig, M.; Wilhelm, K.; Schultze-Seemann, W.; Nestel, S.; Schaefer, G.; Bu, H.; Klocker, H.; Nazarenko, I.; Cato, A. C. B.
    2014. OncoTarget, 5 (18), 8681-8689. doi:10.18632/oncotarget.2365
  14. Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L.
    Cato, L.; Neeb, A.; Brown, M.; Cato, A. C. B.
    2014. Nuclear Receptor Signaling, 12, e005/1-15. doi:10.1621/nrs.12005
  15. Formation of pathologic oligomers in SBMA.
    Jochum, T.; Brinkmann, F.; Ritz, M. E.; Bauer, M.; Moss, D. A.; Cato, A. C. B.
    2014. 22nd Annual Meeting of the Israel Society for Neuroscience (ISFN) and 2nd Binational Italy-Israel Neuroscience Meeting, Eilat, IL, December 14-17, 2013 Journal of Molecular Neuroscience, 53(2014) Suppl.1, (Abstract)
  16. Localization and Dynamics of Glucocorticoid Receptor at the Plasma Membrane of Activated Mast Cells.
    Oppong, E.; Hedde, P. N.; Sekula-Neuner, S.; Brinkmann, F.; Ambili, M.; Dörlich, R. M.; Hirtz, M.; Fuchs, H.; Nienhaus, G. U.; Cato, A. C. B.
    2014. Small, 10 (10), 1991-1998. doi:10.1002/smll.201303677
  17. Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.
    Bruchmann, A.; Roller, C.; Walther, T. V.; Schäfer, G.; Lehmusvaara, S.; Visakorpi, T.; Klocker, H.; Cato, A. C. B.; Maddalo, D.
    2013. BMC Cancer, 13, 96. doi:10.1186/1471-2407-13-96
  18. Stimulated emission depletion-based raster image correlation spectroscopy reveals biomolecular dynamics in live cells.
    Hedde, P. N.; Dörlich, R. M.; Blomley, R.; Gradl, D.; Oppong, E.; Cato, A. C. B.; Nienhaus, G. U.
    2013. Nature Communications, 4, 2093. doi:10.1038/ncomms3093
  19. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells.
    Kullmann, M. K.; Grubbauer, C.; Goetsch, K.; Jäkel, H.; Podmirseg, S. R.; Trockenbacher, A.; Ploner, C.; Cato, A. C. B.; Weiss, C.; Kofler, R.; Hengst, L.
    2013. Cell Cycle, 12, 2625-2635. doi:10.4161/cc.25622
  20. 'SEGRAs' and beyond.
    Cato, A. C. B.
    2013. Molecular and Cellular Endocrinology, 380, 1. doi:10.1016/j.mce.2013.06.011
  21. Molecular mechanisms of glucocorticoid action in mast cells.
    Oppong, E.; Flink, N.; Cato, A. C. B.
    2013. Molecular and Cellular Endocrinology, 380, 119-126. doi:10.1016/j.mce.2013.05.014
  22. Membrane localization of glucocorticoid receptor in mast cells activated on allergen arrays.
    Sekula-Neuner, S.; Oppong, E.; Hedde, P. N.; Nienhaus, G. U.; Cato, A. C. B.; Fuchs, H.
    2013. International Mastcell and Basophil Meeting, Udine, I, August 28-30, 2013
  23. Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type Iα of protein kinase A in vivo.
    Eder, I. E.; Egger, M.; Neuwirt, H.; Seifarth, C.; Maddalo, D.; Desiniotis, A.; Schäfer, G.; Puhr, M.; Bektic, J.; Cato, A. C. B.; Klocker, H.
    2013. International Journal of Molecular Sciences, 14, 11942-11962. doi:10.3390/ijms140611942
  24. A potent and selective small molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune deseases.
    He, Y.; Liu, S.; Menon, A.; Stanford, S. M.; Oppong, E.; Gunawan, A. M.; Wu, L.; Wu, D. J.; Barrios, A. M.; Bottini, N.; Cato, A. C. B.; Zhang, Z. Y.
    2013. Journal of Medicinal Chemistry, 56, 4990-5008. doi:10.1021/jm400248c
  25. Anterior gradient 2 and 3 - two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
    Bu, H.; Schweiger, M. R.; Manke, T.; Wunderlich, A.; Timmermann, B.; Kerick, M.; Pasqualini, L.; Shehu, E.; Fuchsberger, C.; Cato, A. C. B.; Klocker, H.
    2013. FEBS Journal, 280, 1249-1266. doi:10.1111/febs.12118
  26. Magnetic heating effect of nanoparticles with different sizes and size distributions.
    Müller, R.; Dutz, S.; Neeb, A.; Cato, A. C. B.; Zeisberger, M.
    2013. Journal of Magnetism and Magnetic Materials, 328, 80-85. doi:10.1016/j.jmmm.2012.09.064
  27. A Peptidic Unconjugated GRP78/BiP Ligand Modulates the Unfolded Protein Response and Induces Prostate Cancer Cell Death.
    Maddalo, D.; Neeb, A.; Jehle, K.; Schmitz, K.; Shatkina, L.; Muhle-Goll, C.; Walther, T.; Gopal, S. M.; Wenzel, W.; Ulrich, A. S.; Cato, A. C. B.
    2012. PloS One, 7 (10), e45690/1-14. doi:10.1371/journal.pone.0045690
  28. Micropatterned surfaces as tools for the study of the rapid non-genomic actions of steroid receptors.
    Cato, A. C. B.; Oppong, E.; Sekula-Neuner, S.
    2012. Castoria, G. [Hrsg.] Advances in Rapid Sex-Steroid Action : New Challenges and New Chances in Breast and Prosate Cancers New York, N.Y [u.a.] : Springer Science and Business Media, 2012, 253-266
  29. Knockout of Mkp-1 exacerbates colitis in Il-10-deficient mice.
    Matta, R.; Barnard, J. A.; Wancket, L. M.; Yan, J.; Xue, J.; Grieves, J.; Frazier, W. J.; Nelin, L.; Cato, A. C. B.; Liu, Y.
    2012. American Journal of Physiology - Gastrointestinal and Liver Physiology, 302, G1322-G1335. doi:10.1152/ajpgi.00018.2012
  30. The Bcl-2 associated athanogene 5 inhibits stress induces apoptosis and enhances chemoresistance in prostate cancer cells.
    Bruchmann, A.; Roller, C.; Walther, T. V.; Cato, A. C. B.; Maddalo, D.
    2012. Molecularly Targeted Therapies: Mechanisms of Resistance, San Diego, Calif., May 9-12, 2012 Clinical Cancer Research, 18(2012) No.10 Suppl., A62 (Abstract). doi:10.1158/1078-0432.MECHRES-A62
  31. What is a name? [Editorial].
    Cato, A. C. B.; Fuller, P. J.
    2012. Molecular and Cellular Endocrinology, 350 (2), 145. doi:10.1016/j.mce.2011.08.011
  32. Allergen arrays for antibody screening and immune cell activation profiling generated by parallel lipid dip-pen nanolithography.
    Sekula-Neuner, S.; Maier, J.; Oppong, E.; Cato, A. C. B.; Hirtz, M.; Fuchs, H.
    2012. Small, 8, 585-591. doi:10.1002/smll.201101694
  33. PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice.
    Obiri, D. D.; Flink, N.; Maier, J. V.; Neeb, A.; Maddalo, D.; Thiele, W.; Menon, A.; Stassen, M.; Kulkarni, R. A.; Garabedian, M. J.; Barrios, A. M.; Cato, A. C. B.
    2012. Allergy, 67, 175-182. doi:10.1111/j.1398-9995.2011.02731.x
  34. Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures.
    Jochum, T.; Ritz, M. E.; Schuster, C.; Funderburk, S. F.; Jehle, K.; Schmitz, K.; Brinkmann, F.; Hirtz, M.; Moss, D.; Cato, A. C. B.
    2012. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1822, 1070-1078. doi:10.1016/j.bbadis.2012.02.006
  35. Bag-1 proteins inhibit prostate cancer cell growth through a distinct sequence that binds the glucose regulated protein GRP78.
    Maddalo, D.; Neeb, A.; Jehle, K.; Schmitz, K.; Walther, T.; Shatkina, L.; Muhle-Goll, C.; Gopal, S. M.; Wenzel, W.; Ulrich, A. S.; Cato, A. C. B.
    2011. 3rd Internat.Meeting on Cell Stress and Apoptosis - to Arturo, Salerno, I, June 23-25, 2011
  36. Dip-pen nanolithography and TIRF microscopy as tools for the study of the localisation and dynamic behaviour of the GR at the plasma membrane of mast cells.
    Oppong, E.; Hedde, N.; Sekula-Neuner, S.; Fuchs, H.; Nienhaus, G. U.; Cato, A. C. B.
    2011. Nuclear Receptors : From Molecular Mechanism to Health and Disease, EMBO Meeting, Sitges, E, September 16-20, 2011
  37. Steroid hormones regulation of metastasis-associated chaperone proteins agr2 and agr3 in prostate cancer cells.
    Bu, H.; Schweiger, M.; Fuchsberger, C.; Wunderlich, A.; Timmermann, B.; Kerick, M.; Manke, T.; Cato, A. C. B.; Klocker, H.
    2011. 26th Annual Congress of the European Association of Urology, Wien, A, March 18-22, 2011 European Urology Supplements, 10(2011) (Abstract)
  38. Steroid hormones regulation of metastasis-associated chaperone proteins agr2 and agr3 in prostate cancer cells.
    Bu, H.; Schweiger, M.; Fuchsberger, C.; Wunderlich, A.; Timmermann, B.; Kerick, M.; Manke, T.; Cato, A. C. B.; Klocker, H.
    2011. European urology / Supplements, 26th Annual Congress of the European Association of Urology, Wien, A, March 18-22, 2011, (Abstract), 10, 264-265
  39. Pro-apoptotic properties of Bag-1 peptides in the control of prostate cancer cell growth.
    Maddalo, D.; Neeb, A.; Jehle, K.; Schmitz, K.; Shatkina, L.; Muhle-Goll, C.; Gopal, S. M.; Wenzel, W.; Ulrich, A. S.; Cato, A. C. B.
    2011. 102nd Annual Meeting of the American Association for Cancer Research (AACR), Orlando, Fla., April 2-6, 2011 Cancer Research, 71(2011) Nr.8, Suppl.1 Abstract 5403
  40. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
    Bu, H.; Bormann, S.; Schäfer, G.; Horninger, W.; Massoner, P.; Neeb, A.; Lakshmanan, V. K.; Maddalo, D.; Nestl, A.; Sültmann, H.; Cato, A. C. B.; Klocker, H.
    2011. The Prostate, 71, 575-587. doi:10.1002/pros.21273
  41. Depletion of the cellular levels of Bag-1 proteins attenuates phorbol ester-induced downregulation of IκBα and nuclear accumulation of NF-κB.
    Maier, J. V.; Volz, Y.; Berger, C.; Schneider, S.; Cato, A. C. B.
    2010. Biochemical and Biophysical Research Communications, 401, 406-11. doi:10.1016/j.bbrc.2010.09.067
  42. Cross-talk between the p38α and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation.
    Staples, C. J.; Owens, D. M.; Maier, J. V.; Cato, A. C. B.; Keyse, S. M.
    2010. Journal of Biological Chemistry, 285, 25928-25940. doi:10.1074/jbc.M110.117911
  43. Mast cell activation on allergen arrays prepared by lipid dip-pen nanolithography.
    Sekula-Neuner, S.; Maier, J.; Obiri, D.; Cato, A. C. B.; Fuchs, H.
    2010. Bioactive Lipids: Biochemistry and Diseases, Keystone Symp.on Molecular and Cellular Biology, Kyoto, J, June 6-11, 2010
  44. Specific N-terminal mutations in the human androgen receptor induce cytotoxicity.
    Funderburk, S. F.; Shatkina, L.; Mink, S.; Weis, Q.; Weg-Remers, S.; Cato, A. C. B.
    2009. Neurobiology of Aging, 30, 1851-64. doi:10.1016/j.neurobiolaging.2007.12.023
  45. Increased inflammation, impaired bacterial clearance, and metabolic disruption after Gram-negative sepsis in Mkp-1-deficient mice.
    Frazier, J.; Wang, X.; Wancket, L. M.; Li, X. A.; Meng, X.; Nelin, L. D.; Cato, A. C. B.; Liu, Y.
    2009. Journal of Immunology, 183, 7411-19. doi:10.4049/jimmunol.0804343
  46. Protein templating and cell culture on lipid nanoarrays.
    Sekula-Neuner, S.; Fuchs, J.; Weg-Remers, S.; Ellmark, P.; Borrebaeck, C. A. K.; Siebenbrock, J.; Seibold, P.; Schunck, T.; Fischer, R.; Maier, J.; Cato, A. C.; Engin, S.; Wedlich, D.; Welle, A.; Fuchs, H.; Lenhert, S.
    2009. CFN Summer School on Nano-Biology, Bad Herrenalb, September 8-11, 2009
  47. Regulation of hAG-2 and hAG-3 transcripts inprostate cancer.
    Bu, H.; Seifarth, C.; Schäfer, G.; Cato, A. C. B.; Klocker, H.
    2008. 32nd FEBS Congress, Wien, A, July 7-12,2007 FEBS Journal, 274(2007) Suppl.1, (Abstract)
  48. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1.
    Lemke, U.; Krones-Herzig, A.; Diaz, M. B.; Narvekar, P.; Ziegler, A.; Vegiopoulos, A.; Cato, A. C. B.; Bohl, S.; Klingmüller, U.; Screaton, R. A.; Müller-Decker, K.; Kersten, S.; Herzig, S.
    2008. Cell Metabolism, 8, 212-23. doi:10.1016/j.cmet.2008.08.001
  49. Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
    Horsch, K.; de Wet, H.; Schuurmans, M. M.; Allie-Reid, F.; Cato, A. C. B.; Cunningham, J.; Burrin, J. M.; Hough, F. S.; Hulley, P. A.
    2007. Molecular Endocrinology, 21, 2929-40. doi:10.1210/me.2007-0153
  50. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids.
    Maier, J. V.; Brema, S.; Tuckermann, J.; Herzer, U.; Klein, M.; Stassen, M.; Moorthy, A.; Cato, A. C. B.
    2007. Molecular Endocrinology, 21, 2663-71. doi:10.1210/me.2007-0067
  51. Overexpression and gene amplification of BAG-IL in hormone-refractory prostate cancer.
    Mäki, H. E.; Saramäki, O. R.; Shatkina, L.; Martikainen, P. M.; Tammela, T. L. J.; van Weerden, W. M.; Vessella, R. L.; Cato, A. C. B.; Visakorpi, T.
    2007. Journal of Pathology, 212, 395-401. doi:10.1002/path.2186
  52. Nuclear hormome receptors: regulators of gene transcription and cellular signalling.
    Cato, A. C. B.; Shatkina, L.
    2007. Ganten, D. [Hrsg.] Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine Berlin [u.a.] : Springer, 2006, 1314-20
  53. Light-inducible and clock-controlled expression of MAP kinase phosphatase 1 in mouse central pacemaker neurons.
    Doi, M.; Cho, S.; Yujnovsky, I.; Hirayama, J.; Cermakian, N.; Cato, A. C. B.; Sassone-Corsi, P.
    2007. Journal of Biological Rhythms, 22, 127-39. doi:10.1177/0748730406298332
  54. Androgen receptor, polyglutamine stretch amplification and motor neuropathy.
    Cato, A. C. B.
    2007. Androgens 2006, Cambridge, GB, September 25-27, 2007
  55. SBMA pathology and phosphorylation of the androgen receptor.
    Funderburk, S.; Shatkina, L.; Mink, S.; Weis, Q.; Cato, A. C. B.
    2007. Neurodegenerative Diseases : Molecular Mechanisms in a Functional Genomics Framework, Berlin, September 6-9, 2006
  56. Glucocorticoid receptor: an integrator of multiple signal transduction pathways and diverse physiological processes.
    Cato, A. C. B.
    2007. Omics Informatics Symp., Tokyo, J, March 20-21, 2006
  57. Ultra-sensitive detection of proteins by a bio-barcode nanoparticle approach using a micro-magnetic reactor.
    Schneider, S.; Eberhardt, P.; Herzer, U.; Theilacker, N.; Berensmeier, S.; Rogge, T.; Weiß, C.; Cato, A. C. B.
    2006. 2nd FRONTIERS Annual Meeting, Acireale, I, October 24-26, 2006
  58. Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation.
    Gonzalez-Santiago, L.; Suarez, Y.; Zarich, N.; Munoz-Alonso, M. J.; Cuadrado, A.; Tormo, T.; Maier, J. V.; Moorthy, A.; Cato, A. C. B.; Rojas, J. M.; Munoz, A.
    2006. Cell Death and Differentiation, 13, 1968-81. doi:10.1038/sj.cdd.4401898
  59. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
    Schäcke, H.; Rehwinkel, H.; Asadullah, K.; Cato, A. C. B.
    2006. Experimental Dermatology, 15, 565-73. doi:10.1111/j.1600-0625.2006.00453.x
  60. Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
    Zhang, C. W.; Kolb, A.; Büchler, P.; Cato, A. C. B.; Mattern, J.; Rittgen, W.; Edler, L.; Debatin, K. M.; Büchler, M. W.; Friess, H.; Herr, I.
    2006. BMC Cancer, 6, 61. doi:10.1186/1471-2407-6-61
  61. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock.
    Hammer, M.; Mages, J.; Dietrich, H.; Servatius, A.; Howells, N.; Cato, A. C. B.; Lang, R.
    2006. Journal of Experimental Medicine, 203, 15-20. doi:10.1084/jem.20051753
  62. Androgen receptor.
    Cato, A. C. B.
    2005. European Congress of Endocrinology, Göteborg, S, September 3-7, 2005
  63. SBMA pathology and phosphorylation of the androgen receptor.
    Funderburk, S.; Shatkina, L.; Weis, Q.; Huber, A.; Cato, A. C. B.
    2005. 2nd Meeting on Molecular Mechanisms of Neurodegeneration, Milano, I, May 7-10, 2005
  64. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker, H. C.; Hanrahan, S.; Totty, N.; Gamble, S. C.; Waxman, J.; Cato, A. C. B.; Hurst, H. C.; Bevan, C. L.
    2004. Clinical Cancer Research, 10, 7392-7401
  65. The glucocorticoid receptor as target for classic and novel anti-inflammatory therapy.
    Cato, A. C. B.; Schäcke, H.; Sterry, W.; Asadullah, K.
    2004. Current Drug Targets - Inflammation & Allergy, 3, 345-51
  66. Molecular chaperones and cochaperones as regulators of the nuclear action of steroid receptors.
    Cato, A. C. B.
    2004. Graduate College 340 - Methods to Determine the Structure of Proteins and Cellular Components, Hirschegg, A, September 11-18, 2004
  67. Polyglutamine stretch amplification in androgen receptor and neurotoxicity: lessons from Drosophila melanogaster.
    Cato, A. C. B.
    2004. Symp.on Androgen Receptor Function (Androgen 2004), Berlin, October 7-8, 2004
  68. Glucocorticoids synergize with IL-1ß to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells.
    Sakai, A.; Han, J. H.; Cato, A. C. B.; Akira, S.; Li, J. D.
    2004. BMC Molecular Biology, 2, 5. doi:10.1186/1471-2199-5-2
  69. The androgen receptor: molecular biology.
    Klocker, H.; Gromoll, J.; Cato, A. C. B.
    2004. Nieschlag, E. [Hrsg.] Testosterone : Action, Deficiency, Substitution Cambridge : Cambridge Univ.Press, 2004
  70. Androgen receptor cross-talk and implications for intersex phenotype.
    Cato, A. C. B.
    2004. Intersex - from Gene to Gender, Lübeck, April 1-3, 2004
  71. The cochaperone Bag-1 as a ligand activated repressor of glucocorticoid receptor action.
    Hong, W.; Herzer, U.; Martin, E.; Cato, A. C. B.
    2004. 16th Internat.Symp.of the Journal of Steroid Biochemistry and Molecular Biology, Seefeld, A, June 5-8, 2004
  72. Non-classical signaling and cross-talk of androgen receptor.
    Cato, A. C. B.
    2004. 6th European Federation of Endocrine Societies Postgraduate Course in Molecular and Cellular Endocrinology, Berlin, June 27-29, 2003 7th European Federation of Endocrine Societies Postgraduate Course in Molecular and Cellular Endocrinology, Berlin, October 3-5, 2004
  73. Membrane localization and rapid non-transcriptional action of the androgen receptor.
    Mink, S.; Shatkina, L.; Nestl, A.; Cato, A. C. B.
    2004. Watson, C.S. [Hrsg.] The Identities of Membrane Steroid Receptors :. and Other Proteins Mediating Nongenomic Steroid Action Dordrecht : Kluwer Acad.Publ., 2003, 111-17
  74. The Cochaperone Bag-1L enhances androgen receptor action via interaction with the NH₂-terminal region of the receptor.
    Shatkina, L.; Mink, S.; Rogatsch, H.; Klocker, H.; Langer, G.; Nestl, A.; Cato, A. C. B.
    2003. Molecular and Cellular Biology, 23, 7189-97. doi:10.1128/MCB.23.20.7189-7197.2003
  75. Rapid signaling and cross-talk by androgen receptor.
    Cato, A. C. B.
    2003. 3rd Internat.Meeting on Rapid Responses to Steroid Hormones, Firenze, I, September 12-14, 2003
  76. Attenuation of IgE-receptor signalling in mast cells as a molecular basis for the antiallergic action of glucocorticoids.
    Sancono, A.; Kassel, O.; Maier, J.; Hesslinger, C.; Cato, A. C. B.
    2003. 1st ERS Lung Science Conf., Taormina, I, March 28-30, 2003 FEBS Young Scientist Forum, Bruxelles, B, July 1-3, 2003 European Respiratory Journal, 22(2003) Suppl., S-41S
  77. Attenuation of IgE-receptor signalling in mast cells as a molecular basis for the antiallergic action of glucocorticoids.
    Sancono, A.; Kassel, O.; Maier, J.; Hesslinger, C.; Cato, A. C. B.
    2003. European Respiratory Journal, 1st ERS Lung Science Conf., Taormina, I, March 28-30, 2003 FEBS Young Scientist Forum, Bruxelles, B, July 1-3, 2003, Suppl., S-41S, 22, 40
  78. Inhibition of p38 MAPK by glucocorticoid via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2.
    Imasato, A.; Desbois-Mouthon, C.; Han, J.; Kai, H.; Cato, A. C. B.; Akira, S.; Li, J. D.
    2003. Journal of Biological Chemistry, (2002), 277, 47444-50
  79. Mast cells as targets for glucocorticoids in the treatment of allergic disorders.
    Kassel, O.; Cato, A. C. B.
    2002. Cato, A.C.B. [Hrsg.] Recent Advances in Glucocorticoid Receptor Action Berlin [u.a.] : Springer, 2002 (Ernst Schering Research Foundation Workshop ; 40), 153-76
  80. Regulation of androgen receptor action by a chaperone-cochaperone complex, composed of BAG-1L and HSP70.
    Shatkina, L.; Mink, S.; Langer, G.; Cato, A. C. B.
    2002. Symp.on Androgen Receptor Function, Groot Begijnhof, Leuven, B, September 13-14, 2002
  81. Functional analysis of human androgen receptor with a polyglutamine stretch amplification.
    Korali, Z.; Weih, D.; Zinke, I.; Abert, S.; Huber, A.; Paulsen, R.; Cato, A. C. B.
    2002. 2nd European Congress of Andrology, Malmö, S, September 19-22, 2002
  82. Rapid actions of steroid receptors in cellular signaling pathways.
    Cato, A. C. B.; Nestl, A.; Mink, S.
    2002. Science, 's STKE Signal Transduction Knowledge Environment, (2002) Issue 138, re9
  83. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase.
    Shuto, T.; Imasato, A.; Jono, H.; Sakai, A.; Xu, H.; Watanabe, T.; Rixter, D. D.; Kai, H.; Andalibi, A.; Linthicum, F.; Guan, Y. L.; Han, J.; Cato, A. C. B.; Lim, D. J.; Akira, S.; Li, J. D.
    2002. Journal of Biological Chemistry, 277, 17263-70
  84. Warum scheitert die Antihormontherapie bei fortgeschrittenem Prostatakrebs?.
    Cato, A. C. B.; Shatkina, L.; Nestl, A.; Mink, S.
    2002. Nachrichten - Forschungszentrum Karlsruhe, 34, 41-48
  85. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
    Dotzlaw, H.; Moehren, U.; Mink, S.; Cato, A. C. B.; Iniguez Lluhi, J. A.; Baniahmad, A.
    2002. Molecular Endocrinology, 16, 661-73
  86. Dichotomy of glucocorticoid action in the immune system.
    Asadullah, K.; Schäcke, H.; Cato, A. C. B.
    2002. Trends in Immunology, 23, 120-22
  87. Interdigital apoptosis and downregulation of BAG-1 expression in mouse autopods.
    Crocoll, A.; Herzer, U.; Ghyselinck, N. B.; Chambon, P.; Cato, A. C. B.
    2002. Mechanisms of Development, 111, 149-52
  88. Glucocorticoids inhibit MAP-kinase via increased expression and decreased degradation of MKP-1.
    Kassel, O.; Sancono, A.; Krätzschmar, J.; Kreft, B.; Cato, A. C. B.
    2002. Keystone Symp.'Protein Phosphorylation and Mechanisms of Cellular Regulation (X2)', Taos, N.M., March 5-10, 2002
  89. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.
    Kassel, O.; Sancono, A.; Krätzschmar, J.; Kreft, B.; Stassen, M.; Cato, A. C. B.
    2002. The EMBO Journal, (2001), 20, 7108-16
  90. A Drosophila model for the functional analysis of human androgen receptor with a polyglutamine stretch amplification.
    Korali, Z.; Weih, D.; Abert, S.; Mink, S.; Huber, A.; Paulsen, R.; Zinke, I.; Pankratz, M. J.; Cato, A. C. B.
    2002. Keystone Symp.'Nuclear Receptor Superfamily (D4)', Snowbird, Utah, April 13-19, 2002
  91. BAG-1 family of cochaperones in the modulation of nuclear receptor action.
    Cato, A. C. B.; Mink, S.
    2002. Journal of Steroid Biochemistry and Molecular Biology, (2001), 78, 379-88
  92. A Drosophila model for spinal and bulbar muscular atrophy.
    Korali, Z.; Weih, D.; Mink, S.; Huber, A.; Paulsen, R.; Zinke, I.; Pankratz, M. J.; Cato, A. C. B.
    2001. Nuclear Receptors in Health and Disease, Mont Saint Odile, F, September 14-17, 2001
  93. BAG-1 family of cochaperones in the modulation of nuclear receptor action.
    Crocoll, A.; Mink, S.; Hübner, S.; Schneikert, J.; Cato, A. C. B.
    2001. Current Topics in Steroid Research, 3, 53-62
  94. Modulation of glucocorticoid- and androgen receptor action by Bag-1 cochaperones.
    Mink, S.; Schneikert, J.; Hong, W.; Shatkina, L.; Cato, A. C. B.
    2001. Euro Conf.and EMBO Workshop, Sant Feliu de Guixols, E, May 26-31, 2001
  95. Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis.
    Sourisseau, T.; Desbois, C.; Debure, L.; Bowtell, D. D. L.; Cato, A. C. B.; Schneikert, J.; Moyse, E.; Michel, D.
    2001. Journal of Cell Science, 114, 1409-16
  96. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.
    Doppler, W.; Windegger, M.; Soratroi, C.; Tomasi, J.; Lechner, J.; Rusconi, S.; Cato, A. C. B.; Almlöf, T.; Liden, J.; Okret, S.; Gustafson, J. A.; Richard-Foy, H.; Starr, D. B.; Klocker, H.; Edwards, D.; Geymayer, S.
    2001. Molecular and Cellular Biology, 21, 3266-79
  97. Hsp70-RAP46 interaction in downregulation of DNA binding by glucocorticoid receptor.
    Schneikert, J.; Hübner, S.; Langer, G.; Petri, T.; Jäättelä, M.; Reed, J.; Cato, A. C. B.
    2000. The EMBO Journal, 19, 6508-16
  98. Modulation of androgen receptor action.
    Shatkina, L.; Mink, S.; Becker, M.; Cato, A. C. B.
    2000. Symp.on Androgen Receptor Function - Androgens 2000, Rotterdam, NL, September 22-23, 2000
  99. BAG-1M: a potential specificity determinant of corticosteroid receptor action.
    Crocoll, A.; Schneikert, J.; Hübner, S.; Martin, E.; Cato, A. C. B.
    2000. Kidney International, 57, 1265-69
  100. Isoform-specific expression of BAG-1 in mouse development.
    Crocoll, A.; Blum, M.; Cato, A. C. B.
    2000. Mechanisms of Development, 91, 355-59
  101. Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch.
    Becker, M.; Martin, E.; Schneikert, J.; Krug, H. F.; Cato, A. C. B.
    2000. The Journal of Cell Biology, 149, 255-62
  102. How to produce androgen antagonists.
    Cato, A. C. B.; Mink, S.; Becker, M.; Shatkina, L.
    2000. Meeting of the European Society of Human Reproduction and Embryology, Bologna, I, June 25-28, 2000
  103. Rapid signalling by androgen receptor in prostate cancer cells.
    Peterziel, H.; Mink, S.; Schonert, A.; Becker, M.; Klocker, H.; Cato, A. C. B.
    1999. Oncogene, 18, 6322-29
  104. A nuclear action of the Eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity.
    Schneikert, J.; Hübner, S.; Martin, E.; Cato, A. C. B.
    1999. The Journal of Cell Biology, 146, 929-40
  105. Androgen receptor signalling pathways: role of BAG-IL in androgen receptor action.
    Shatkina, L.; Mink, S.; Cato, A. C. B.
    1999. 28.Colloquium Endocrinologicum, Heidelberg, 5.November 1999
  106. Die Rolle der Kerntranslokation des Co-Chaperons RAP46 in der Regulation der transaktivierenden Wirkung des Glucocorticoidrezeptors.
    Hübner, S.; Schneickert, J.; Martin, E.; Cato, A. C. B.
    1999. 28.Colloquium Endocrinologicum, Heidelberg, 5.November 1999
  107. Steroid hormone receptors and their coactivators and corepressors.
    Cato, A. C. B.
    1999. 3rd Postgraduate Course in Molecular and Cellular Endocrinology, European Federation of Endocrine Societies, Münster, July 7-11, 1999
  108. Mechanism of androgen receptor activation and possible implications for chemoprevention trials.
    Klocker, H.; Culig, Z.; Eder, I. E.; Nessler-Menardi, C.; Hobisch, A.; Putz, T.; Bartsch, G.; Peterziel, H.; Cato, A. C. B.
    1999. European Urology, 35, 413-19
  109. Androgen receptor action: two receptors-two ligands theory revisited.
    Cato, A. C. B.
    1999. Round Table Discussion on PR and AR Isoforms, Schering AG, Berlin, July 5, 1999
  110. Eukaryotic cochaperone RAP46/BAG-1M as potential specificity determinant in corticosteroid receptor action.
    Schneikert, J.; Hübner, S.; Crocoll, A.; Martin, E.; Cato, A. C. B.
    1999. Forefront Meeting of the Internat.Soc.of Nephrology 'News in Aldosterone Action', Paris, F, August 15-18, 1999
  111. The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription.
    Ortiz, L.; Aza-Blanc, P.; Zannini, M.; Cato, A. C. B.; Santisteban, P.
    1999. The Journal of Biological Chemistry, 274, 15213-21
  112. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.
    Culig, Z.; Hobisch, A.; Hittmair, A.; Peterziel, H.; Cato, A. C. B.; Bartsch, G.; Klocker, H.
    1999. The Prostate, (1998), 35, 63-70
  113. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
    Rodrigo, I.; Cato, A. C. B.; Cano, A.
    1999. Experimental Cell Research, 248, 358-71
  114. Androgen receptor signaling in prostate cancer cells.
    Cato, A. C. B.; Krug, H. F.; Peterziel, H.
    1999. 23.Jahrestagung der Deutschen Gesellschaft für Zellbiologie, Rostock, 14.-18.März 1999